Table 1.
Definitions of clinical TNM according AJCC 2010 [21].
Table 2.
Pathological TNM according AJCC 2010 [21]. There is no pT1 classification.
Table 3.
Anatomic stage/prognostic groups (from AJCC 2010) [21].
Fig 1.
Neuro-Fuzzy Prostate Cancer Pathological Stage Predictor.
Table 4.
Dataset Statistics.
Table 5.
Primary and Secondary Gleason pattern groups.
Fig 2.
Histogram of grouped PSA values.
Table 6.
PSA groups.
Table 7.
Age groups.
Table 8.
Clinical T stage groups.
Table 9.
Pathological T (pT) stage groups.
Table 10.
Before data normalisation.
Table 11.
After data normalisation.
Fig 3.
Histogram of grouped age values.
Table 12.
PSA levels categorised by age group.
Table 13.
Mean and Standard deviation values for Organ-Confined Disease (OCD) and Extra-Prostatic Disease (ED) groups diagnosed at the Pathological stage.
Fig 4.
Neuro-Fuzzy System Membership Functions: Gleason 1 is Primary Gleason Pattern; Gleason 2 is Secondary Gleason pattern; PSA is Prostate Specific Antigen; Age represents the Age group; and clinical T stage is the result of the Digital Rectal Examination.
OCD is Organ-Confined Disease and ED is Extra-Prostatic Disease.
Table 14.
Performance evaluation.
Fig 5.
Performance Comparison.
Fig 6.
ROC Curves: Performance Comparison.
Table 15.
Support Vector Machine(SVM) performance evaluation when applying various kernel functions.
Table 16.
Naive Bayes(NB) performance evaluation using the Gaussian distribution and Kernel Density Estimation functions.